Zurcher Kantonalbank (Zurich Cantonalbank) Amicus Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 50,471 shares of FOLD stock, worth $491,082. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,471

Previous 50,471 -0.0%

Holding current value

$491,082

Previous $539,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$9.04 - $11.75 $26,378 - $34,286	2,918 Added 6.14%	50,471 $500,000
Q1 2024 Apr 25, 2024	SELL	$11.43 - $14.24 $12,813 - $15,963	-1,121 Reduced 2.3%	47,553 $560,000
Q4 2023 Jan 30, 2024	BUY	$9.97 - $14.52 $63,279 - $92,158	6,347 Added 15.0%	48,674 $690,000
Q3 2023 Oct 25, 2023	BUY	$11.78 - $13.86 $53,104 - $62,480	4,508 Added 11.92%	42,327 $514,000
Q2 2023 Aug 07, 2023	BUY	$10.72 - $13.3 $31,366 - $38,915	2,926 Added 8.39%	37,819 $475,000
Q1 2023 May 08, 2023	SELL	$10.91 - $13.54 $272 - $338	-25 Reduced 0.07%	34,893 $386,000
Q4 2022 Feb 01, 2023	BUY	$9.89 - $12.7 $48,777 - $62,636	4,932 Added 16.45%	34,918 $426,000
Q1 2022 Apr 21, 2022	BUY	$7.89 - $12.48 $16,884 - $26,707	2,140 Added 7.69%	29,986 $284,000
Q4 2021 Feb 01, 2022	SELL	$9.82 - $12.44 $2,435 - $3,085	-248 Reduced 0.88%	27,846 $322,000
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $78 - $106	9 Added 0.03%	28,094 $268,000
Q2 2021 Jul 30, 2021	SELL	$8.71 - $10.72 $34,900 - $42,955	-4,007 Reduced 12.49%	28,085 $271,000
Q1 2021 May 03, 2021	BUY	$9.2 - $23.86 $22,622 - $58,671	2,459 Added 8.3%	32,092 $317,000
Q4 2020 Jan 28, 2021	SELL	$13.47 - $24.89 $23,626 - $43,657	-1,754 Reduced 5.59%	29,633 $684,000
Q2 2020 Jul 28, 2020	BUY	$8.86 - $15.69 $65,882 - $116,670	7,436 Added 31.05%	31,387 $473,000
Q1 2020 May 06, 2020	BUY	$6.63 - $11.16 $35,629 - $59,973	5,374 Added 28.93%	23,951 $221,000
Q4 2019 Jan 21, 2020	BUY	$7.48 - $10.75 $27,496 - $39,517	3,676 Added 24.67%	18,577 $181,000
Q3 2019 Oct 18, 2019	SELL	$8.02 - $13.25 $10,105 - $16,695	-1,260 Reduced 7.8%	14,901 $120,000
Q2 2019 Jul 30, 2019	BUY	$10.96 - $14.4 $61,321 - $80,568	5,595 Added 52.95%	16,161 $202,000
Q1 2019 Apr 29, 2019	SELL	$10.04 - $13.92 $13,644 - $18,917	-1,359 Reduced 11.4%	10,566 $144,000
Q1 2018 May 03, 2018	BUY	$13.76 - $17.12 $30,395 - $37,818	2,209 Added 22.74%	11,925 $179,000
Q4 2017 Jan 31, 2018	BUY	$12.51 - $16.24 $32,250 - $41,866	2,578 Added 36.12%	9,716 $140,000
Q3 2017 Nov 08, 2017	BUY	$11.74 - $15.78 $83,800 - $112,637	7,138	7,138 $108,000

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.73B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Amicus Therapeutics, Inc. Transaction History